Phillip Kurs

Phillip Kurs is a Regulatory Counsel in the Center for Biologics Evaluation and Research (CBER). He has worked at FDA since 2016, having joined CBER in 2021 after previously working in FDA's Center for Drug Evaluation and Research. Prior to his time at FDA Phillip worked as an attorney in private practice.